Mink Therapeutics (NasdaqCM:INKT) Q4 2025 Earnings call March 31, 2026 08:30 AM ET Company ParticipantsEmily Bodnar - VP of Equity ResearchJennifer Buell - President and CEOMayank Mamtani - Senior Managing Director and Group Head of Healthcare ResearchMelissa Orilall - Principal Financial OfficerStephanie Perna-Nacar - Chief Communications OfficerOperatorGood morning, and welcome to MiNK Therapeutics' fourth quarter and year-end 2025 financial results conference call. All participants will be in a listen-on ...

Mink Therapeutics (NasdaqCM:INKT) Q4 2025 Earnings call March 31, 2026 08:30 AM ET Company ParticipantsEmily Bodnar - VP of Equity ResearchJennifer Buell - President and CEOMayank Mamtani - Senior Managing Director and Group Head of Healthcare ResearchMelissa Orilall - Principal Financial OfficerStefanie Perna-Nacar - Chief Communications OfficerOperatorGood morning, and welcome to MiNK Therapeutics' fourth quarter and year-end 2025 financial results conference call. All participants will be in a listen-onl ...

Mink Therapeutics (NasdaqCM:INKT) Q4 2025 Earnings call March 31, 2026 08:30 AM ET Speaker4Good morning, and welcome to MiNK Therapeutics' fourth quarter and year-end 2025 financial results conference call. All participants will be in a listen-only mode until the question and answer session. As a reminder, this event is being recorded. If anyone has any objections, you may disconnect at this time. I would now like to turn the conference over to Stephanie Pernicaro, Chief Communications Officer. Please go ah ...